- Published on
Emergency And Acute Medicine – Diabetes Insipidus
Overview And Definition
Diabetes insipidus is a disorder characterized by excretion of abnormally large volumes of dilute urine due to impaired action of arginine vasopressin. Polyuria is typically defined as urine output exceeding 3 liters in 24 hours and is often accompanied by excessive thirst and fluid intake. Two major forms exist: central diabetes insipidus, caused by deficient synthesis or release of vasopressin, and nephrogenic diabetes insipidus, caused by renal resistance to vasopressin. Familial cases occur in both forms, with some nephrogenic cases inherited in an X-linked recessive pattern.
Causes And Risk Factors
Central diabetes insipidus results from disruption of the hypothalamic–pituitary axis and is most common between 10 and 20 years of age. Causes include head trauma, neurosurgery, pituitary or hypothalamic tumors such as craniopharyngioma or germinoma, metastatic disease, granulomatous disorders, congenital CNS anomalies, CNS infections, pregnancy-related pituitary injury, idiopathic autoimmune processes, Wolfram syndrome, and ethanol use. Nephrogenic diabetes insipidus arises from intrinsic renal pathology or impaired tubular response to vasopressin and may be due to congenital renal disorders, obstructive uropathy, polycystic kidney disease, systemic diseases such as sickle cell disease or amyloidosis, medications such as lithium, amphotericin, aminoglycosides, and demeclocycline, or electrolyte disturbances including hypercalcemia and hypokalemia.
Pregnancy-Related Considerations
Transient diabetes insipidus may occur during the second trimester due to increased circulating vasopressinase, leading to reduced vasopressin activity. Symptoms usually resolve within weeks after delivery. Desmopressin is effective because it is resistant to vasopressinase. Sheehan syndrome is another pregnancy-related cause of central diabetes insipidus.
Clinical Features And Presentation
Patients commonly report marked polyuria, sometimes producing 16–24 liters of urine daily, along with intense polydipsia, often preferring cold fluids. Additional features may include medication exposure or symptoms suggestive of hypothalamic or pituitary tumors such as headache, visual changes, growth abnormalities, obesity, temperature dysregulation, sleep disturbance, or behavioral changes. Physical examination may reveal dehydration, cachexia, head trauma signs, visual field deficits, or seizures.
Pediatric Presentation
In children, polyuria and polydipsia may go unrecognized until dehydration develops. Neonates may present at birth and are at risk for severe hypernatremia and permanent neurologic injury if untreated. Infants may show irritability, poor feeding, weight loss, constipation, growth failure, recurrent fever, or abnormal behavior. Older children may present with enuresis or difficulty with toilet training.
Essential Emergency Evaluation
In the emergency setting, the diagnosis is largely clinical, supported by hypernatremia with copious dilute urine output. A careful history of fluid intake, voiding frequency, medication use, and physical findings is essential.
Diagnostic Studies And Interpretation
Urinalysis typically shows low specific gravity. Serum and urine osmolality reveal elevated serum osmolality with inappropriately low urine osmolality. Electrolyte testing may demonstrate hypernatremia, hypercalcemia, or hypokalemia. Renal function tests and glucose help exclude other causes of polyuria. Serum and urine vasopressin levels are not required in the emergency department. Imaging such as CT or chest radiography may be indicated for trauma or malignancy evaluation, while MRI of the pituitary axis is usually performed outpatient. Water deprivation testing is not recommended in the emergency setting because of safety concerns, especially in hypotensive patients and children.
Differential Diagnosis
Alternative considerations include inadequate access to free water, excessive insensible losses, primary sodium excess, psychogenic polydipsia, diuretic use, osmotic diuresis, resolving acute renal failure, and uncontrolled diabetes mellitus.
Initial And Emergency Management
Initial care focuses on airway, breathing, and circulation, with attention to possible head trauma. Hypotension should be treated with isotonic saline. Because intravascular volume represents a small fraction of total water deficit, careful correction is required. Central diabetes insipidus is treated with desmopressin, administered intranasally, orally, intravenously, or subcutaneously in divided doses. Caution is required in postoperative patients due to risk of cerebral edema. Nephrogenic diabetes insipidus is managed by treating the underlying cause, discontinuing offending medications, correcting electrolyte abnormalities, implementing dietary sodium restriction, and using thiazide diuretics, often with amiloride. NSAIDs such as indomethacin may reduce urine output. Parenteral free-water replacement is reserved for symptomatic hypernatremia when oral intake is not possible.
Medication Therapy
Common agents include desmopressin in various formulations, thiazide diuretics, amiloride, and in selected cases chlorpropamide or clofibrate for partial central disease. Aqueous vasopressin has limited use due to short half-life and adverse effects.
Disposition And Follow-Up
Admission is indicated for altered mental status, seizures, severe dehydration, significant electrolyte abnormalities, associated trauma, or need for diagnostic testing under observation. Patients with a known diagnosis, stable electrolytes, and adequate hydration may be discharged with close follow-up. Referral to endocrinology or nephrology depends on the underlying etiology.
Key Clinical Insights And Pitfalls
Always consider diabetes insipidus in patients with unexplained polyuria and low urine osmolality. Central diabetes insipidus typically responds to desmopressin, whereas nephrogenic diabetes insipidus does not and requires management of renal resistance and contributing factors.
Overview And Definition
Diabetes insipidus is a disorder characterized by excretion of abnormally large volumes of dilute urine due to impaired action of arginine vasopressin. Polyuria is typically defined as urine output exceeding 3 liters in 24 hours and is often accompanied by excessive thirst and fluid intake. Two major forms exist: central diabetes insipidus, caused by deficient synthesis or release of vasopressin, and nephrogenic diabetes insipidus, caused by renal resistance to vasopressin. Familial cases occur in both forms, with some nephrogenic cases inherited in an X-linked recessive pattern.
Causes And Risk Factors
Central diabetes insipidus results from disruption of the hypothalamic–pituitary axis and is most common between 10 and 20 years of age. Causes include head trauma, neurosurgery, pituitary or hypothalamic tumors such as craniopharyngioma or germinoma, metastatic disease, granulomatous disorders, congenital CNS anomalies, CNS infections, pregnancy-related pituitary injury, idiopathic autoimmune processes, Wolfram syndrome, and ethanol use. Nephrogenic diabetes insipidus arises from intrinsic renal pathology or impaired tubular response to vasopressin and may be due to congenital renal disorders, obstructive uropathy, polycystic kidney disease, systemic diseases such as sickle cell disease or amyloidosis, medications such as lithium, amphotericin, aminoglycosides, and demeclocycline, or electrolyte disturbances including hypercalcemia and hypokalemia.
Pregnancy-Related Considerations
Transient diabetes insipidus may occur during the second trimester due to increased circulating vasopressinase, leading to reduced vasopressin activity. Symptoms usually resolve within weeks after delivery. Desmopressin is effective because it is resistant to vasopressinase. Sheehan syndrome is another pregnancy-related cause of central diabetes insipidus.
Clinical Features And Presentation
Patients commonly report marked polyuria, sometimes producing 16–24 liters of urine daily, along with intense polydipsia, often preferring cold fluids. Additional features may include medication exposure or symptoms suggestive of hypothalamic or pituitary tumors such as headache, visual changes, growth abnormalities, obesity, temperature dysregulation, sleep disturbance, or behavioral changes. Physical examination may reveal dehydration, cachexia, head trauma signs, visual field deficits, or seizures.
Pediatric Presentation
In children, polyuria and polydipsia may go unrecognized until dehydration develops. Neonates may present at birth and are at risk for severe hypernatremia and permanent neurologic injury if untreated. Infants may show irritability, poor feeding, weight loss, constipation, growth failure, recurrent fever, or abnormal behavior. Older children may present with enuresis or difficulty with toilet training.
Essential Emergency Evaluation
In the emergency setting, the diagnosis is largely clinical, supported by hypernatremia with copious dilute urine output. A careful history of fluid intake, voiding frequency, medication use, and physical findings is essential.
Diagnostic Studies And Interpretation
Urinalysis typically shows low specific gravity. Serum and urine osmolality reveal elevated serum osmolality with inappropriately low urine osmolality. Electrolyte testing may demonstrate hypernatremia, hypercalcemia, or hypokalemia. Renal function tests and glucose help exclude other causes of polyuria. Serum and urine vasopressin levels are not required in the emergency department. Imaging such as CT or chest radiography may be indicated for trauma or malignancy evaluation, while MRI of the pituitary axis is usually performed outpatient. Water deprivation testing is not recommended in the emergency setting because of safety concerns, especially in hypotensive patients and children.
Differential Diagnosis
Alternative considerations include inadequate access to free water, excessive insensible losses, primary sodium excess, psychogenic polydipsia, diuretic use, osmotic diuresis, resolving acute renal failure, and uncontrolled diabetes mellitus.
Initial And Emergency Management
Initial care focuses on airway, breathing, and circulation, with attention to possible head trauma. Hypotension should be treated with isotonic saline. Because intravascular volume represents a small fraction of total water deficit, careful correction is required. Central diabetes insipidus is treated with desmopressin, administered intranasally, orally, intravenously, or subcutaneously in divided doses. Caution is required in postoperative patients due to risk of cerebral edema. Nephrogenic diabetes insipidus is managed by treating the underlying cause, discontinuing offending medications, correcting electrolyte abnormalities, implementing dietary sodium restriction, and using thiazide diuretics, often with amiloride. NSAIDs such as indomethacin may reduce urine output. Parenteral free-water replacement is reserved for symptomatic hypernatremia when oral intake is not possible.
Medication Therapy
Common agents include desmopressin in various formulations, thiazide diuretics, amiloride, and in selected cases chlorpropamide or clofibrate for partial central disease. Aqueous vasopressin has limited use due to short half-life and adverse effects.
Disposition And Follow-Up
Admission is indicated for altered mental status, seizures, severe dehydration, significant electrolyte abnormalities, associated trauma, or need for diagnostic testing under observation. Patients with a known diagnosis, stable electrolytes, and adequate hydration may be discharged with close follow-up. Referral to endocrinology or nephrology depends on the underlying etiology.
Key Clinical Insights And Pitfalls
Always consider diabetes insipidus in patients with unexplained polyuria and low urine osmolality. Central diabetes insipidus typically responds to desmopressin, whereas nephrogenic diabetes insipidus does not and requires management of renal resistance and contributing factors.
0 Comments
